These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 28855400)
41. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging. Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758 [TBL] [Abstract][Full Text] [Related]
42. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares. Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Caselli RJ; Reiman EM Neuroimage; 2012 May; 60(4):2316-22. PubMed ID: 22348880 [TBL] [Abstract][Full Text] [Related]
43. Sex and menopause impact Jett S; Dyke JP; Andy C; Schelbaum E; Jang G; Boneu Yepez C; Pahlajani S; Diaz I; Diaz Brinton R; Mosconi L Sci Rep; 2022 Dec; 12(1):22087. PubMed ID: 36543814 [TBL] [Abstract][Full Text] [Related]
46. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not. Sang S; Pan X; Chen Z; Zeng F; Pan S; Liu H; Jin L; Fei G; Wang C; Ren S; Jiao F; Bao W; Zhou W; Guan Y; Zhang Y; Shi H; Wang Y; Yu X; Wang Y; Zhong C Alzheimers Res Ther; 2018 Mar; 10(1):26. PubMed ID: 29490669 [TBL] [Abstract][Full Text] [Related]
47. Role of family history for Alzheimer biomarker abnormalities in the adult children study. Xiong C; Roe CM; Buckles V; Fagan A; Holtzman D; Balota D; Duchek J; Storandt M; Mintun M; Grant E; Snyder AZ; Head D; Benzinger TL; Mettenburg J; Csernansky J; Morris JC Arch Neurol; 2011 Oct; 68(10):1313-9. PubMed ID: 21987546 [TBL] [Abstract][Full Text] [Related]
49. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease. Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938 [TBL] [Abstract][Full Text] [Related]
50. Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents. Mosconi L; Rinne JO; Tsui WH; Murray J; Li Y; Glodzik L; McHugh P; Williams S; Cummings M; Pirraglia E; Goldsmith SJ; Vallabhajosula S; Scheinin N; Viljanen T; Någren K; de Leon MJ Neurobiol Aging; 2013 Jan; 34(1):22-34. PubMed ID: 22503001 [TBL] [Abstract][Full Text] [Related]
51. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation. Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411 [TBL] [Abstract][Full Text] [Related]
52. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305 [TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging. Jagust WJ; Landau SM; J Neurosci; 2012 Dec; 32(50):18227-33. PubMed ID: 23238736 [TBL] [Abstract][Full Text] [Related]
54. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects. Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959 [TBL] [Abstract][Full Text] [Related]
55. Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease. Dukart J; Kherif F; Mueller K; Adaszewski S; Schroeter ML; Frackowiak RS; Draganski B; PLoS Comput Biol; 2013 Apr; 9(4):e1002987. PubMed ID: 23592957 [TBL] [Abstract][Full Text] [Related]
56. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469 [TBL] [Abstract][Full Text] [Related]
57. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease. Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136 [TBL] [Abstract][Full Text] [Related]